Surgical Innovations Group Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Şu anda Surgical Innovations Group için büyüme ve gelir tahmini yapmak üzere yeterli analist kapsamımız yok.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Medical Equipment kazanç büyümesi	23.1%
Gelir büyüme oranı	n/a
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	Low
Son güncelleme	18 Apr 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Surgical Innovations Group plc (LON:SUN) Shares Fly 63% But Investors Aren't Buying For Growth

Jul 11

Surgical Innovations Group plc's (LON:SUN) Share Price Is Matching Sentiment Around Its Revenues

Apr 19

Investors Don't See Light At End Of Surgical Innovations Group plc's (LON:SUN) Tunnel And Push Stock Down 33%

Dec 29

Returns On Capital At Surgical Innovations Group (LON:SUN) Paint A Concerning Picture

Sep 07

Surgical Innovations Group (LON:SUN) Has Some Difficulty Using Its Capital Effectively

May 26

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Surgical Innovations Group yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

AIM:SUN - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (GBP Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2024	12	N/A	1	N/A	1
6/30/2024	13	-1	-1	0	N/A
3/31/2024	12	-1	0	0	N/A
12/31/2023	12	-1	0	0	N/A
9/30/2023	12	0	-1	0	N/A
6/30/2023	12	0	-1	0	N/A
3/31/2023	11	0	-1	0	N/A
12/31/2022	11	0	-1	0	N/A
9/30/2022	11	0	-1	0	N/A
6/30/2022	10	0	-1	0	N/A
3/31/2022	10	0	-1	0	N/A
12/31/2021	9	0	-1	0	N/A
9/30/2021	9	-1	0	0	N/A
6/30/2021	8	-1	0	0	N/A
3/31/2021	7	-2	1	1	N/A
12/31/2020	6	-3	1	1	N/A
9/30/2020	7	-4	1	1	N/A
6/30/2020	8	-5	1	1	N/A
3/31/2020	9	-4	0	1	N/A
12/31/2019	11	-3	0	1	N/A
9/30/2019	11	-1	0	1	N/A
6/30/2019	11	0	0	1	N/A
3/31/2019	11	1	1	1	N/A
12/31/2018	11	1	1	2	N/A
9/30/2018	11	1	1	2	N/A
6/30/2018	11	0	1	2	N/A
3/31/2018	10	0	N/A	2	N/A
12/31/2017	9	0	N/A	2	N/A
9/30/2017	8	1	N/A	2	N/A
6/30/2017	7	1	N/A	2	N/A
3/31/2017	6	1	N/A	2	N/A
12/31/2016	6	1	N/A	3	N/A
9/30/2016	6	0	N/A	3	N/A
6/30/2016	6	0	N/A	3	N/A
3/31/2016	6	-1	N/A	2	N/A
12/31/2015	5	-2	N/A	2	N/A
9/30/2015	5	-5	N/A	1	N/A
6/30/2015	5	-9	N/A	0	N/A
3/31/2015	4	-9	N/A	0	N/A
12/31/2014	4	-9	N/A	0	N/A
9/30/2014	5	-6	N/A	0	N/A
6/30/2014	5	-3	N/A	1	N/A
3/31/2014	6	-1	N/A	1	N/A
12/31/2013	7	0	N/A	1	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: SUN 'un tahmini kazanç büyümesinin tasarruf oranının ( 1.9% ) üzerinde olup olmadığını belirlemek için yeterli veri yok.

Kazançlar ve Piyasa: SUN 'un kazançlarının UK pazarından daha hızlı büyümesinin öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Yüksek Büyüme Kazançları: SUN şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artıp artmayacağını belirlemek için yeterli veri bulunmuyor.

Gelir ve Pazar: SUN şirketinin gelirinin UK pazarından daha hızlı büyüyeceğinin tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Yüksek Büyüme Geliri: SUN şirketinin gelirinin yıllık 20% oranından daha hızlı artacağının tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: SUN 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Surgical Innovations Group Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Surgical Innovations Group plc Provides Revenue Guidance for the Year Ended 31 December 2022

Surgical Innovations Group plc Provides Revenue Guidance for the Six Months to 30 June 2022

Price target decreased to UK£0.033

Surgical Innovations Group plc Provides Revenue Guidance for the Full Year 2021

Recent updates

First half 2024 earnings released: UK£0.001 loss per share (vs UK£0 in 1H 2023)

New major risk - Financial position

Surgical Innovations Group plc to Report First Half, 2024 Results on Sep 30, 2024

Surgical Innovations Group plc (LON:SUN) Shares Fly 63% But Investors Aren't Buying For Growth

Surgical Innovations Group plc, Annual General Meeting, Jun 17, 2024

New major risk - Share price stability

Surgical Innovations Group plc's (LON:SUN) Share Price Is Matching Sentiment Around Its Revenues

Full year 2023 earnings released

Surgical Innovations Group plc to Report Fiscal Year 2023 Results on Apr 18, 2024

New minor risk - Financial data availability

New minor risk - Share price stability

Surgical Innovations Group plc Announces Intention of Paul Hardy to Step Down from Position of Independent Non-Executive Director

Investors Don't See Light At End Of Surgical Innovations Group plc's (LON:SUN) Tunnel And Push Stock Down 33%

Charmaine Day Notifies the Board of Her Intention to Step Down from Her Role as Chief Financial Officer of Surgical Innovations Group plc

Surgical Innovations Group plc Announces Board Change

First half 2023 earnings released: EPS: UK£0 (vs UK£0 in 1H 2022)

Surgical Innovations Group plc to Report First Half, 2023 Results on Sep 19, 2023

Returns On Capital At Surgical Innovations Group (LON:SUN) Paint A Concerning Picture

Surgical Innovations Group plc, Annual General Meeting, Jun 27, 2023

Surgical Innovations Group (LON:SUN) Has Some Difficulty Using Its Capital Effectively

Surgical Innovations Group plc Appoints Jonathan Glenn as Senior Independent Non-Executive Director and Chairman-Designate

Full year 2022 earnings released: EPS: UK£0 (vs UK£0 in FY 2021)

Surgical Innovations Group plc Provides Revenue Guidance for the Year Ended 31 December 2022

Less than half of directors are independent

First half 2022 earnings released: EPS: UK£0 (vs UK£0 in 1H 2021)

Surgical Innovations Group plc to Report First Half, 2022 Results on Sep 21, 2022

Surgical Innovations Group plc Ordinary Shares to Be Deleted from OTC Equity

Surgical Innovations Group plc Provides Revenue Guidance for the Six Months to 30 June 2022

Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Surgical Innovations Group plc, Annual General Meeting, Jun 27, 2022

Price target decreased to UK£0.033

Less than half of directors are independent

Surgical Innovations Group plc Provides Revenue Guidance for the Full Year 2021

Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Full year 2020 earnings released: UK£0.004 loss per share (vs UK£0.003 loss in FY 2019)

Health Check: How Prudently Does Surgical Innovations Group (LON:SUN) Use Debt?

Full year 2020 earnings released: UK£0.004 loss per share (vs UK£0.003 loss in FY 2019)

Surgical Innovations Group plc to Report Fiscal Year 2020 Results on Mar 25, 2021

Surgical Innovations Group plc Announces New USA Distribution Agreement with Microline Surgical Inc

Surgical Innovations Group plc Announces Adam Power Will Retire as Group Development Director, with Effect from 31 December 2021

Surgical Innovations Group plc Announces Distribution Agreement with Adler Instrument Company Inc

Surgical Innovations Group plc Announces its Collaboration with the Centre for Sustainable Healthcare

First half earnings released

Surgical Innovations Group plc to Report First Half, 2020 Results on Sep 08, 2020

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Büyüyen şirketleri keşfedin